Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

This study has been terminated.
(Sponsor decision)
Sponsor:
Information provided by (Responsible Party):
KangLaiTe USA
ClinicalTrials.gov Identifier:
NCT01483586
First received: November 28, 2011
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)